Legal Representation
Attorney
David A Farah
USPTO Deadlines
Application History
11 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 9, 2003 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Apr 8, 2003 | NOAM | O | NOA MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jan 14, 2003 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Dec 25, 2002 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Nov 1, 2002 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Oct 25, 2002 | CNEA | O | EXAMINERS AMENDMENT MAILED | Loading... |
| Oct 8, 2002 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 19, 2002 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Aug 19, 2002 | I | PAPER RECEIVED | Loading... | |
| Jul 15, 2002 | CNRT | F | NON-FINAL ACTION MAILED | Loading... |
| Jun 27, 2002 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Detailed Classifications
Class 001
Reagents for scientific or medical research for use with proteins, protein drugs, and protein growth factors
First Use Anywhere:
0
First Use in Commerce:
0
Class 005
Pharmaceuticals, namely proteins, protein drugs and protein growth factors for the diagnosis and treatment of neoplastic diseases, diseases and conditions of the hematopoietic system, neurologic system and gastrointestinal system, and for organ regeneration; proteins and protein growth factors for ex-vivo expansion and proliferation of stem cells; clinical medical reagents for use with proteins, protein drugs and protein growth factors
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
001
005